Guobang Pharma Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 2, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	14,350	11,513	9,813	14,792	16,111	-
Market Cap Growth	28.60%	17.32%	-33.66%	-8.19%	-	-
Enterprise Value	13,103	10,267	8,306	12,684	13,589	-
Last Close Price	25.95	20.23	16.76	24.60	26.56	-
PE Ratio	16.54	14.73	16.02	16.06	22.82	-
Forward PE	15.51	10.92	11.33	-	-	-
PS Ratio	2.41	1.95	1.83	2.59	3.58	-
PB Ratio	1.73	1.43	1.32	2.07	2.54	-
P/TBV Ratio	1.81	1.50	1.39	2.18	2.65	-
P/FCF Ratio	24.03	40.07	-	69.15	-	-
P/OCF Ratio	13.30	16.30	18.99	14.54	-	-
EV/Sales Ratio	2.21	1.74	1.55	2.22	3.02	-
EV/EBITDA Ratio	9.31	8.09	8.74	10.48	13.37	-
EV/EBIT Ratio	14.71	12.27	13.20	13.35	16.66	-
EV/FCF Ratio	21.95	35.74	-	59.29	-	-
Debt / Equity Ratio	0.12	0.10	0.13	0.09	0.03	0.28
Debt / EBITDA Ratio	0.68	0.61	1.02	0.55	0.17	0.79
Debt / FCF Ratio	1.61	2.72	-	3.11	-	3.73
Asset Turnover	0.56	0.56	0.55	0.69	0.69	0.82
Inventory Turnover	3.05	3.26	2.98	3.08	2.79	3.05
Quick Ratio	2.03	1.52	1.45	1.93	2.40	0.92
Current Ratio	3.20	2.30	2.22	2.75	3.96	1.46
Return on Equity (ROE)	10.79%	10.08%	8.36%	13.64%	14.68%	27.51%
Return on Assets (ROA)	5.25%	4.95%	4.05%	7.17%	7.83%	12.23%
Return on Invested Capital (ROIC)	11.23%	12.11%	10.13%	18.00%	19.50%	32.60%
Return on Capital Employed (ROCE)	10.10%	10.20%	8.00%	13.20%	12.80%	28.40%
Earnings Yield	6.08%	6.79%	6.24%	6.23%	4.38%	-
FCF Yield	4.16%	2.50%	-2.36%	1.45%	-3.88%	-
Dividend Yield	2.33%	2.99%	1.80%	2.44%	2.63%	-
Payout Ratio	40.77%	24.83%	59.05%	13.92%	47.27%	23.21%
Buyback Yield / Dilution	0.21%	-0.27%	0.24%	-9.09%	-8.01%	0.28%
Total Shareholder Return	2.42%	2.73%	2.04%	-6.65%	-5.37%	0.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.